25 XP   0   0   10

Sana Biotechnology Inc
Buy, Hold or Sell?

Let's analyse Sana together

PenkeI guess you are interested in Sana Biotechnology Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sana Biotechnology Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sana Biotechnology Inc

I send you an email if I find something interesting about Sana Biotechnology Inc.

Quick analysis of Sana (30 sec.)










What can you expect buying and holding a share of Sana? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.30
Expected worth in 1 year
$0.34
How sure are you?
17.6%

+ What do you gain per year?

Total Gains per Share
$-0.96
Return On Investment
-9.6%

For what price can you sell your share?

Current Price per Share
$10.00
Expected price per share
$8.22 - $12.00
How sure are you?
50%

1. Valuation of Sana (5 min.)




Live pricePrice per Share (EOD)

$10.00

Intrinsic Value Per Share

$-13.90 - $-16.17

Total Value Per Share

$-12.59 - $-14.87

2. Growth of Sana (5 min.)




Is Sana growing?

Current yearPrevious yearGrowGrow %
How rich?$287.5m$601.6m-$242.4m-67.5%

How much money is Sana making?

Current yearPrevious yearGrowGrow %
Making money-$70.3m-$66.3m-$3.9m-5.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Sana (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#189 / 1031

Most Revenue
#863 / 1031

Most Profit
#958 / 1031

Most Efficient
#317 / 1031

What can you expect buying and holding a share of Sana? (5 min.)

Welcome investor! Sana's management wants to use your money to grow the business. In return you get a share of Sana.

What can you expect buying and holding a share of Sana?

First you should know what it really means to hold a share of Sana. And how you can make/lose money.

Speculation

The Price per Share of Sana is $10. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sana.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sana, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.30. Based on the TTM, the Book Value Change Per Share is $-0.24 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sana.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.40-4.0%-0.32-3.2%-0.31-3.1%-0.33-3.3%-0.33-3.3%
Usd Book Value Change Per Share-0.36-3.6%-0.24-2.4%-0.26-2.6%0.080.8%0.080.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.36-3.6%-0.24-2.4%-0.26-2.6%0.080.8%0.080.8%
Usd Price Per Share4.08-4.30-6.16-7.82-7.82-
Price to Earnings Ratio-2.55-52.28--6.49-12.26-12.26-
Price-to-Total Gains Ratio-11.48-9.81--30.42-0.45-0.45-
Price to Book Ratio3.13-2.71-2.22-2.56-2.56-
Price-to-Total Gains Ratio-11.48-9.81--30.42-0.45-0.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10
Number of shares100
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.240.08
Usd Total Gains Per Share-0.240.08
Gains per Quarter (100 shares)-24.027.67
Gains per Year (100 shares)-96.0830.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-96-10603121
20-192-20206152
30-288-29809283
40-384-3940123114
50-480-4900153145
60-576-5860184176
70-673-6820215207
80-769-7780245238
90-865-8740276269
100-961-9700307300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%2.015.00.011.8%2.015.00.011.8%2.015.00.011.8%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%3.012.02.017.6%3.012.02.017.6%3.012.02.017.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%3.012.02.017.6%3.012.02.017.6%3.012.02.017.6%

Fundamentals of Sana

About Sana Biotechnology Inc

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, B-cell-mediated autoimmune, and others. The company's product candidates include SC291 that is used as allogeneic cell therapies for hematologic malignancies; ARDENT for a potential treatment for non-Hodgkin's lymphoma, and chronic lymphoblastic leukemia; GLEAM, to treat multiple autoimmune disorders that involve production of autoimmune antibodies, including lupus nephritis, extrarenal lupus, antineutrophil cytoplasmic antibody -associated vasculitis, and others. It is developing SC262 to treat patients with relapsed and/or refractory B-cell malignancies; SC255 for multiple myeloma treatment; SC379, a therapy for patients with certain central nervous system disorders healthy allogeneic glial progenitor cells; SC451, a product candidate to treat diabetes, with an initial focus on type 1 diabetes mellitus; and UP421 that reduces long-term exogenous insulin dependence. The company has an option and license agreement with Beam Therapeutics Inc. for use of Beam's proprietary CRISPR Cas12b nuclease editing technology to research, develop, and commercialize engineered cell therapy products; and a license agreement with Harvard College to access certain intellectual property for the development of hypoimmune-modified cells. The company was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. Sana Biotechnology, Inc. was incorporated in 2018 and is headquartered in Seattle, Washington.

Fundamental data was last updated by Penke on 2024-03-22 03:18:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Sana Biotechnology Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sana earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sana to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sana Biotechnology Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-4.1%+4.1%
5Y-4.1%10Y-4.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM--202.3%+202.3%
YOY--263.0%+263.0%
5Y-4.1%-452.4%+448.3%
10Y-4.1%-589.0%+584.9%
1.1.2. Return on Assets

Shows how efficient Sana is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sana to the Biotechnology industry mean.
  • -15.6% Return on Assets means that Sana generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sana Biotechnology Inc:

  • The MRQ is -15.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.6%TTM-10.6%-5.0%
TTM-10.6%YOY-7.3%-3.3%
TTM-10.6%5Y-9.5%-1.0%
5Y-9.5%10Y-9.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.6%-12.5%-3.1%
TTM-10.6%-12.2%+1.6%
YOY-7.3%-11.2%+3.9%
5Y-9.5%-13.3%+3.8%
10Y-9.5%-14.6%+5.1%
1.1.3. Return on Equity

Shows how efficient Sana is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sana to the Biotechnology industry mean.
  • -30.6% Return on Equity means Sana generated $-0.31 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sana Biotechnology Inc:

  • The MRQ is -30.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -20.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-30.6%TTM-20.3%-10.3%
TTM-20.3%YOY-11.6%-8.7%
TTM-20.3%5Y-10.1%-10.2%
5Y-10.1%10Y-10.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-30.6%-16.0%-14.6%
TTM-20.3%-15.8%-4.5%
YOY-11.6%-13.9%+2.3%
5Y-10.1%-18.2%+8.1%
10Y-10.1%-19.1%+9.0%

1.2. Operating Efficiency of Sana Biotechnology Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sana is operating .

  • Measures how much profit Sana makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sana to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sana Biotechnology Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-4.2%+4.2%
5Y-4.2%10Y-4.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM--208.5%+208.5%
YOY--280.2%+280.2%
5Y-4.2%-459.9%+455.7%
10Y-4.2%-596.9%+592.7%
1.2.2. Operating Ratio

Measures how efficient Sana is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sana Biotechnology Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.041-0.041
5Y0.04110Y0.0410.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM-3.181-3.181
YOY-3.609-3.609
5Y0.0415.554-5.513
10Y0.0417.396-7.355

1.3. Liquidity of Sana Biotechnology Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sana is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.31 means the company has $3.31 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sana Biotechnology Inc:

  • The MRQ is 3.311. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.531. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.311TTM3.531-0.220
TTM3.531YOY4.757-1.226
TTM3.5315Y7.630-4.099
5Y7.63010Y7.6300.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3113.987-0.676
TTM3.5314.440-0.909
YOY4.7575.569-0.812
5Y7.6306.158+1.472
10Y7.6306.492+1.138
1.3.2. Quick Ratio

Measures if Sana is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sana to the Biotechnology industry mean.
  • A Quick Ratio of 4.35 means the company can pay off $4.35 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sana Biotechnology Inc:

  • The MRQ is 4.353. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.861. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.353TTM4.861-0.508
TTM4.861YOY7.518-2.657
TTM4.8615Y10.899-6.039
5Y10.89910Y10.8990.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3533.653+0.700
TTM4.8614.158+0.703
YOY7.5185.515+2.003
5Y10.8996.012+4.887
10Y10.8996.206+4.693

1.4. Solvency of Sana Biotechnology Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sana assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sana to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.49 means that Sana assets are financed with 49.1% credit (debt) and the remaining percentage (100% - 49.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sana Biotechnology Inc:

  • The MRQ is 0.491. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.459. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.491TTM0.459+0.032
TTM0.459YOY0.359+0.101
TTM0.4595Y0.680-0.221
5Y0.68010Y0.6800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4910.336+0.155
TTM0.4590.330+0.129
YOY0.3590.267+0.092
5Y0.6800.367+0.313
10Y0.6800.378+0.302
1.4.2. Debt to Equity Ratio

Measures if Sana is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sana to the Biotechnology industry mean.
  • A Debt to Equity ratio of 96.6% means that company has $0.97 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sana Biotechnology Inc:

  • The MRQ is 0.966. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.857. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.966TTM0.857+0.109
TTM0.857YOY0.561+0.296
TTM0.8575Y0.446+0.411
5Y0.44610Y0.4460.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9660.376+0.590
TTM0.8570.398+0.459
YOY0.5610.334+0.227
5Y0.4460.431+0.015
10Y0.4460.476-0.030

2. Market Valuation of Sana Biotechnology Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sana generates.

  • Above 15 is considered overpriced but always compare Sana to the Biotechnology industry mean.
  • A PE ratio of -2.55 means the investor is paying $-2.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sana Biotechnology Inc:

  • The EOD is -6.254. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.552. Based on the earnings, the company is expensive. -2
  • The TTM is 52.281. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.254MRQ-2.552-3.703
MRQ-2.552TTM52.281-54.833
TTM52.281YOY-6.489+58.770
TTM52.2815Y12.255+40.026
5Y12.25510Y12.2550.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.254-2.697-3.557
MRQ-2.552-2.422-0.130
TTM52.281-2.709+54.990
YOY-6.489-4.116-2.373
5Y12.255-6.257+18.512
10Y12.255-6.478+18.733
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sana Biotechnology Inc:

  • The EOD is -8.350. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.407. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.575. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.350MRQ-3.407-4.943
MRQ-3.407TTM-3.575+0.169
TTM-3.575YOY-4.373+0.798
TTM-3.5755Y-6.735+3.159
5Y-6.73510Y-6.7350.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.350-3.344-5.006
MRQ-3.407-2.939-0.468
TTM-3.575-3.486-0.089
YOY-4.373-5.592+1.219
5Y-6.735-8.464+1.729
10Y-6.735-8.872+2.137
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sana is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.13 means the investor is paying $3.13 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Sana Biotechnology Inc:

  • The EOD is 7.668. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.128. Based on the equity, the company is fair priced.
  • The TTM is 2.711. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD7.668MRQ3.128+4.539
MRQ3.128TTM2.711+0.417
TTM2.711YOY2.223+0.488
TTM2.7115Y2.562+0.149
5Y2.56210Y2.5620.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.6682.198+5.470
MRQ3.1282.042+1.086
TTM2.7112.121+0.590
YOY2.2232.907-0.684
5Y2.5623.682-1.120
10Y2.5624.114-1.552
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Sana Biotechnology Inc.

3.1. Institutions holding Sana Biotechnology Inc

Institutions are holding 79.339% of the shares of Sana Biotechnology Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Flagship Ventures Management, Inc.11.41717.023225001856-8288162-24.8968
2023-09-30FMR Inc7.26020.005315898729-745336-4.4781
2023-12-31Canada Pension Plan Investment Board4.64640.05241017500000
2023-12-31Baillie Gifford & Co Limited.4.6350.032810150017-54358-0.5327
2023-09-30Vanguard Group Inc4.18640.000991675851071671.1828
2023-12-31BlackRock Inc3.86750.000984692224752595.9452
2023-09-30State Street Corporation2.10450.0014608493-229310-4.74
2023-12-31T. Rowe Price Associates, Inc.1.64120.0023594025-3432116-48.8478
2023-09-30Crestline Management LP1.53691.5173336562400
2023-09-30Alphabet Inc1.28430.6991281250000
2023-09-30Geode Capital Management, LLC0.9350.00092047588650583.2816
2023-09-30Baker Bros Advisors LP0.91330.0446200000000
2023-12-31Suvretta Capital Management, LLC0.73340.29631606056-1357648-45.8092
2023-12-31Capital World Investors0.69930.0011153130700
2023-09-30Partner Fund Management LP0.56810.2268124413912301738808.3417
2023-09-30JPMorgan Chase & Co0.53760.00051177332-60466-4.885
2023-12-31Massachusetts Financial Services Company0.4810.00141053330-6810-0.6424
2023-09-30Omega Fund Management LLC0.38532.999184375000
2023-09-30Northern Trust Corp0.38020.0006832607169082.0728
2023-09-30Nuveen Asset Management, LLC0.35230.0011771439-1346-0.1742
Total 48.56512.9073106350599-12280987-11.5%

3.2. Funds holding Sana Biotechnology Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Scottish Mortgage Ord2.53410.18185586252137030.2459
2024-02-29SPDR® S&P Biotech ETF1.86580.52154113122768601.9042
2024-02-29Vanguard Total Stock Mkt Idx Inv1.83220.00264038990100560033.151
2024-01-31Fidelity Growth Compy Commingled Pl O1.71010.028937697721100263.0064
2024-02-29Vanguard Small Cap Index1.50420.0237331590754740819.7727
2024-01-31Fidelity Growth Company Fund1.34810.0298297176417580.0592
2024-02-29iShares Russell 2000 ETF1.04890.03722312280-378-0.0163
2023-12-31T. Rowe Price Health Sciences0.89950.0551982885-41201-2.0355
2023-12-31American Funds SMALLCAP World A0.89060.0111196337800
2024-02-29Vanguard Small Cap Growth Index Inv0.84250.0534185723231489520.4167
2023-12-31Vanguard US Growth Investor0.83470.0188184006600
2024-01-31Baillie Gifford US Equity Growth0.83470.1315184006600
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.64580.0141423753109480.7749
2024-01-31JPM Thematics Genetic Thrps C2 Acc USD0.45470.74351002281-17453-1.7115
2024-01-31Baillie Gifford American B Inc0.45320.1462999077-158823-13.7165
2023-12-31Fidelity Small Cap Index0.43460.0154958140393144.2787
2024-01-31Fidelity Select Biotechnology0.42740.112194219400
2024-01-31Fidelity Growth Company K60.40040.0289882727-12384-1.3835
2024-02-01iShares Russell 2000 Value ETF0.37420.040782498110440.1267
2024-02-29iShares Biotechnology ETF0.34220.0996754381-3395-0.448
Total 19.67792.295743379248+1887922+4.4%

3.3. Insider Transactions

Insiders are holding 9.388% of the shares of Sana Biotechnology Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-08Robert NelsenBUY18181815.5
2023-06-06Ventures Fund V Gener FlagshipSELL2037586.31
2023-05-26Ventures Fund V Gener FlagshipSELL820006.23
2023-05-24Ventures Fund V Gener FlagshipSELL3478706.57

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Sana Biotechnology Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.355-0.240-32%-0.260-27%0.077-563%0.077-563%
Book Value Per Share--1.3041.629-20%2.729-52%1.609-19%1.609-19%
Current Ratio--3.3113.531-6%4.757-30%7.630-57%7.630-57%
Debt To Asset Ratio--0.4910.459+7%0.359+37%0.680-28%0.680-28%
Debt To Equity Ratio--0.9660.857+13%0.561+72%0.446+117%0.446+117%
Dividend Per Share----0%-0%-0%-0%
Eps---0.400-0.321-20%-0.306-24%-0.330-17%-0.330-17%
Free Cash Flow Per Share---0.299-0.310+4%-0.353+18%-0.285-5%-0.285-5%
Free Cash Flow To Equity Per Share---0.292-0.274-6%-0.347+19%0.012-2530%0.012-2530%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---16.170--------
Intrinsic Value_10Y_min---13.898--------
Intrinsic Value_1Y_max---1.356--------
Intrinsic Value_1Y_min---1.331--------
Intrinsic Value_3Y_max---4.275--------
Intrinsic Value_3Y_min---4.077--------
Intrinsic Value_5Y_max---7.437--------
Intrinsic Value_5Y_min---6.886--------
Market Cap2204480000.000+59%899427840.000946824160.000-5%1357959680.000-34%1724033035.294-48%1724033035.294-48%
Net Profit Margin----0%-0%-0.0410%-0.0410%
Operating Margin----0%-0%-0.0420%-0.0420%
Operating Ratio----0%-0%0.041-100%0.041-100%
Pb Ratio7.668+59%3.1282.711+15%2.223+41%2.562+22%2.562+22%
Pe Ratio-6.254-145%-2.55252.281-105%-6.489+154%12.255-121%12.255-121%
Price Per Share10.000+59%4.0804.295-5%6.160-34%7.821-48%7.821-48%
Price To Free Cash Flow Ratio-8.350-145%-3.407-3.575+5%-4.373+28%-6.735+98%-6.735+98%
Price To Total Gains Ratio-28.138-145%-11.4809.815-217%-30.421+165%0.449-2656%0.449-2656%
Quick Ratio--4.3534.861-10%7.518-42%10.899-60%10.899-60%
Return On Assets---0.156-0.106-32%-0.073-53%-0.095-39%-0.095-39%
Return On Equity---0.306-0.203-34%-0.116-62%-0.101-67%-0.101-67%
Total Gains Per Share---0.355-0.240-32%-0.260-27%0.077-563%0.077-563%
Usd Book Value--287506000.000359162250.000-20%601623500.000-52%354683823.529-19%354683823.529-19%
Usd Book Value Change Per Share---0.355-0.240-32%-0.260-27%0.077-563%0.077-563%
Usd Book Value Per Share--1.3041.629-20%2.729-52%1.609-19%1.609-19%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.400-0.321-20%-0.306-24%-0.330-17%-0.330-17%
Usd Free Cash Flow---66005000.000-68403500.000+4%-77731500.000+18%-62755058.824-5%-62755058.824-5%
Usd Free Cash Flow Per Share---0.299-0.310+4%-0.353+18%-0.285-5%-0.285-5%
Usd Free Cash Flow To Equity Per Share---0.292-0.274-6%-0.347+19%0.012-2530%0.012-2530%
Usd Market Cap2204480000.000+59%899427840.000946824160.000-5%1357959680.000-34%1724033035.294-48%1724033035.294-48%
Usd Price Per Share10.000+59%4.0804.295-5%6.160-34%7.821-48%7.821-48%
Usd Profit---88117000.000-70331500.000-20%-66352000.000-25%-72412470.588-18%-72412470.588-18%
Usd Revenue----0%-0%9501588.235-100%9501588.235-100%
Usd Total Gains Per Share---0.355-0.240-32%-0.260-27%0.077-563%0.077-563%
 EOD+5 -3MRQTTM+5 -24YOY+7 -225Y+4 -2710Y+4 -27

4.2. Fundamental Score

Let's check the fundamental score of Sana Biotechnology Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.254
Price to Book Ratio (EOD)Between0-17.668
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.353
Current Ratio (MRQ)Greater than13.311
Debt to Asset Ratio (MRQ)Less than10.491
Debt to Equity Ratio (MRQ)Less than10.966
Return on Equity (MRQ)Greater than0.15-0.306
Return on Assets (MRQ)Greater than0.05-0.156
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Sana Biotechnology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.162
Ma 20Greater thanMa 509.463
Ma 50Greater thanMa 1007.904
Ma 100Greater thanMa 2006.112
OpenGreater thanClose9.990
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets565,299
Total Liabilities277,793
Total Stockholder Equity287,506
 As reported
Total Liabilities 277,793
Total Stockholder Equity+ 287,506
Total Assets = 565,299

Assets

Total Assets565,299
Total Current Assets213,515
Long-term Assets351,784
Total Current Assets
Cash And Cash Equivalents 137,349
Short-term Investments 71,678
Other Current Assets 4,488
Total Current Assets  (as reported)213,515
Total Current Assets  (calculated)213,515
+/-0
Long-term Assets
Property Plant Equipment 145,592
Goodwill 140,627
Intangible Assets 59,195
Long-term Assets Other 6,370
Long-term Assets  (as reported)351,784
Long-term Assets  (calculated)351,784
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities64,487
Long-term Liabilities213,306
Total Stockholder Equity287,506
Total Current Liabilities
Short-term Debt 13,195
Accounts payable 4,108
Other Current Liabilities 47,184
Total Current Liabilities  (as reported)64,487
Total Current Liabilities  (calculated)64,487
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt90,901
Long-term Liabilities Other 122,405
Long-term Liabilities  (as reported)213,306
Long-term Liabilities  (calculated)213,306
+/-0
Total Stockholder Equity
Common Stock20
Retained Earnings -1,338,091
Accumulated Other Comprehensive Income -60
Other Stockholders Equity 1,625,637
Total Stockholder Equity (as reported)287,506
Total Stockholder Equity (calculated)287,506
+/-0
Other
Capital Stock20
Cash and Short Term Investments 209,027
Common Stock Shares Outstanding 197,317
Liabilities and Stockholders Equity 565,299
Net Debt -33,253
Net Invested Capital 287,506
Net Working Capital 149,028
Property Plant and Equipment Gross 187,363
Short Long Term Debt Total 104,096



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
> Total Assets 
415,698
0
0
767,715
730,296
1,304,466
1,259,837
1,232,751
1,129,407
1,047,613
971,089
898,102
822,720
746,928
707,147
631,440
565,299
565,299631,440707,147746,928822,720898,102971,0891,047,6131,129,4071,232,7511,259,8371,304,466730,296767,71500415,698
   > Total Current Assets 
144,263
0
0
455,568
384,467
967,474
860,340
612,845
558,101
523,220
494,414
500,250
444,437
369,908
338,621
279,522
213,515
213,515279,522338,621369,908444,437500,250494,414523,220558,101612,845860,340967,474384,467455,56800144,263
       Cash And Cash Equivalents 
80,030
0
0
149,221
411,995
750,687
675,140
433,670
253,029
188,517
194,659
163,343
176,765
160,456
173,787
168,448
137,349
137,349168,448173,787160,456176,765163,343194,659188,517253,029433,670675,140750,687411,995149,2210080,030
       Short-term Investments 
58,952
0
0
301,640
253,458
209,550
177,696
170,041
297,967
323,861
290,143
322,407
247,198
188,850
152,128
100,122
71,678
71,678100,122152,128188,850247,198322,407290,143323,861297,967170,041177,696209,550253,458301,6400058,952
       Other Current Assets 
5,281
0
0
4,707
6,203
7,237
7,504
9,134
7,105
10,842
9,612
14,500
14,374
14,502
6,606
7,120
4,488
4,4887,1206,60614,50214,37414,5009,61210,8427,1059,1347,5047,2376,2034,707005,281
   > Long-term Assets 
271,435
0
0
312,147
345,829
336,992
399,497
619,906
571,306
524,393
476,675
397,852
378,283
377,020
368,526
351,918
351,784
351,784351,918368,526377,020378,283397,852476,675524,393571,306619,906399,497336,992345,829312,14700271,435
       Property Plant Equipment 
69,314
0
0
101,735
109,943
112,756
119,000
148,273
161,784
165,838
166,756
163,082
159,403
162,376
157,369
145,604
145,592
145,592145,604157,369162,376159,403163,082166,756165,838161,784148,273119,000112,756109,943101,7350069,314
       Goodwill 
140,627
0
0
140,627
140,627
140,627
140,627
140,627
140,627
140,627
140,627
140,627
140,627
140,627
140,627
140,627
140,627
140,627140,627140,627140,627140,627140,627140,627140,627140,627140,627140,627140,627140,627140,62700140,627
       Long Term Investments 
0
0
0
8,209
33,731
21,627
77,934
262,401
195,881
145,014
94,764
25,823
10,051
5,825
0
0
0
0005,82510,05125,82394,764145,014195,881262,40177,93421,62733,7318,209000
       Intangible Assets 
59,195
0
0
59,195
59,195
59,195
59,195
59,195
59,195
59,195
59,195
59,195
59,195
59,195
59,195
59,195
59,195
59,19559,19559,19559,19559,19559,19559,19559,19559,19559,19559,19559,19559,19559,1950059,195
       Other Assets 
2,299
0
0
0
2,333
2,787
2,741
9,410
13,819
13,719
15,333
9,125
9,007
0
11,335
0
0
0011,33509,0079,12515,33313,71913,8199,4102,7412,7872,3330002,299
> Total Liabilities 
558,240
0
0
1,078,890
1,151,480
422,483
353,940
402,666
400,905
345,958
331,584
332,083
323,405
318,666
352,118
265,588
277,793
277,793265,588352,118318,666323,405332,083331,584345,958400,905402,666353,940422,4831,151,4801,078,89000558,240
   > Total Current Liabilities 
19,829
0
0
26,537
31,451
35,150
42,832
92,010
99,235
93,510
97,108
114,813
111,504
102,777
112,105
66,644
64,487
64,48766,644112,105102,777111,504114,81397,10893,51099,23592,01042,83235,15031,45126,5370019,829
       Short-term Debt 
1,848
0
0
3,189
3,712
3,910
6,004
6,502
9,159
9,635
10,667
11,921
12,393
12,892
12,890
13,490
13,195
13,19513,49012,89012,89212,39311,92110,6679,6359,1596,5026,0043,9103,7123,189001,848
       Accounts payable 
0
0
0
3,889
2,253
4,258
3,704
3,947
2,219
4,765
3,079
3,993
2,857
2,334
3,089
9,928
4,108
4,1089,9283,0892,3342,8573,9933,0794,7652,2193,9473,7044,2582,2533,889000
       Other Current Liabilities 
17,981
0
0
19,459
25,486
5,000
5,000
48,459
56,382
79,110
83,362
98,899
96,254
87,551
58,417
43,226
47,184
47,18443,22658,41787,55196,25498,89983,36279,11056,38248,4595,0005,00025,48619,4590017,981
   > Long-term Liabilities 
538,411
0
0
1,052,353
1,120,029
387,333
311,108
310,656
301,670
252,448
234,476
217,270
211,901
215,889
240,013
198,944
213,306
213,306198,944240,013215,889211,901217,270234,476252,448301,670310,656311,108387,3331,120,0291,052,35300538,411
       Capital Lease Obligations 
48,207
0
0
70,650
71,909
70,259
72,153
98,905
110,943
112,153
113,627
111,780
108,253
114,499
113,135
96,864
104,096
104,09696,864113,135114,499108,253111,780113,627112,153110,94398,90572,15370,25971,90970,6500048,207
       Other Liabilities 
74,693
0
0
0
198,935
320,984
244,959
218,253
199,886
149,930
131,516
117,411
116,041
0
139,768
0
0
00139,7680116,041117,411131,516149,930199,886218,253244,959320,984198,93500074,693
       Long-term Liabilities Other 
74,693
0
0
131,995
198,935
320,984
244,959
310,656
301,670
252,448
234,476
217,270
211,901
215,889
139,768
115,570
122,405
122,405115,570139,768215,889211,901217,270234,476252,448301,670310,656244,959320,984198,935131,9950074,693
> Total Stockholder Equity
-142,542
0
0
-311,175
-421,184
881,983
905,897
830,085
728,502
701,655
639,505
566,019
499,315
428,262
355,029
365,852
287,506
287,506365,852355,029428,262499,315566,019639,505701,655728,502830,085905,897881,983-421,184-311,17500-142,542
   Common Stock
1
0
0
1
2
18
18
18
18
19
19
19
19
19
20
20
20
20202019191919191818181821001
   Retained Earnings -1,338,091-1,249,974-1,250,958-1,136,959-1,054,836-974,393-889,273-816,808-785,360-674,629-591,366-610,049-429,432-316,26200-144,127
   Accumulated Other Comprehensive Income 
26
0
0
55
30
56
13
-82
-1,366
-5,172
-6,347
-6,414
-4,327
-2,139
-865
-202
-60
-60-202-865-2,139-4,327-6,414-6,347-5,172-1,366-82135630550026
   Capital Surplus 
0
0
0
0
0
1,491,958
1,497,232
1,504,778
1,515,210
1,523,616
1,535,106
1,546,807
1,558,459
1,567,341
0
0
0
0001,567,3411,558,4591,546,8071,535,1061,523,6161,515,2101,504,7781,497,2321,491,95800000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
1,558
0
0
5,031
8,216
187,492
237,395
272,027
1,515,210
1,523,616
1,535,106
1,546,807
1,558,459
1,567,341
1,606,832
1,616,008
1,625,637
1,625,6371,616,0081,606,8321,567,3411,558,4591,546,8071,535,1061,523,6161,515,210272,027237,395187,4928,2165,031001,558



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-30,865
Gross Profit-30,865-30,865
 
Operating Income (+$)
Gross Profit-30,865
Operating Expense-294,940
Operating Income-325,805-325,805
 
Operating Expense (+$)
Research Development221,641
Selling General Administrative73,299
Selling And Marketing Expenses0
Operating Expense294,940294,940
 
Net Interest Income (+$)
Interest Income9,938
Interest Expense-0
Other Finance Cost-0
Net Interest Income9,938
 
Pretax Income (+$)
Operating Income-325,805
Net Interest Income9,938
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-283,255-368,355
EBIT - interestExpense = -325,805
-283,255
-283,255
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-325,805-283,255
Earnings Before Interest and Taxes (EBITDA)-294,940
 
After tax Income (+$)
Income Before Tax-283,255
Tax Provision-0
Net Income From Continuing Ops-283,255-283,255
Net Income-283,255
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses325,805
Total Other Income/Expenses Net42,550-9,938
 

Technical Analysis of Sana
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sana. The general trend of Sana is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sana's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sana Biotechnology Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12.00.

The bearish price targets are: 8.77 > 8.23 > 8.22.

Tweet this
Sana Biotechnology Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sana Biotechnology Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sana Biotechnology Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sana Biotechnology Inc. The current macd is 0.39740798.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sana price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sana. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sana price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sana Biotechnology Inc Daily Moving Average Convergence/Divergence (MACD) ChartSana Biotechnology Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sana Biotechnology Inc. The current adx is 25.55.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sana shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Sana Biotechnology Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sana Biotechnology Inc. The current sar is 10.16.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sana Biotechnology Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sana Biotechnology Inc. The current rsi is 62.16. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Sana Biotechnology Inc Daily Relative Strength Index (RSI) ChartSana Biotechnology Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sana Biotechnology Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sana price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sana Biotechnology Inc Daily Stochastic Oscillator ChartSana Biotechnology Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sana Biotechnology Inc. The current cci is 76.78.

Sana Biotechnology Inc Daily Commodity Channel Index (CCI) ChartSana Biotechnology Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sana Biotechnology Inc. The current cmo is 30.59.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sana Biotechnology Inc Daily Chande Momentum Oscillator (CMO) ChartSana Biotechnology Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sana Biotechnology Inc. The current willr is -6.34920635.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Sana Biotechnology Inc Daily Williams %R ChartSana Biotechnology Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sana Biotechnology Inc.

Sana Biotechnology Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sana Biotechnology Inc. The current atr is 0.71712375.

Sana Biotechnology Inc Daily Average True Range (ATR) ChartSana Biotechnology Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sana Biotechnology Inc. The current obv is 87,892,137.

Sana Biotechnology Inc Daily On-Balance Volume (OBV) ChartSana Biotechnology Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sana Biotechnology Inc. The current mfi is 46.86.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Sana Biotechnology Inc Daily Money Flow Index (MFI) ChartSana Biotechnology Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sana Biotechnology Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Sana Biotechnology Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sana Biotechnology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.162
Ma 20Greater thanMa 509.463
Ma 50Greater thanMa 1007.904
Ma 100Greater thanMa 2006.112
OpenGreater thanClose9.990
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sana with someone you think should read this too:
  • Are you bullish or bearish on Sana? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sana? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sana Biotechnology Inc

I send you an email if I find something interesting about Sana Biotechnology Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Sana Biotechnology Inc.

Receive notifications about Sana Biotechnology Inc in your mailbox!